These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 22396185

  • 1. Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo.
    Chen M, Huang SL, Zhang XQ, Zhang B, Zhu H, Yang VW, Zou XP.
    J Cell Biochem; 2012 Jul; 113(7):2474-87. PubMed ID: 22396185
    [Abstract] [Full Text] [Related]

  • 2. Effects of proton pump inhibitors on reversing multidrug resistance via downregulating V-ATPases/PI3K/Akt/mTOR/HIF-1α signaling pathway through TSC1/2 complex and Rheb in human gastric adenocarcinoma cells in vitro and in vivo.
    Chen M, Lu J, Wei W, Lv Y, Zhang X, Yao Y, Wang L, Ling T, Zou X.
    Onco Targets Ther; 2018 Jul; 11():6705-6722. PubMed ID: 30349304
    [Abstract] [Full Text] [Related]

  • 3. Effects and mechanisms of proton pump inhibitors as a novel chemosensitizer on human gastric adenocarcinoma (SGC7901) cells.
    Chen M, Zou X, Luo H, Cao J, Zhang X, Zhang B, Liu W.
    Cell Biol Int; 2009 Sep; 33(9):1008-19. PubMed ID: 19501661
    [Abstract] [Full Text] [Related]

  • 4. Proton pump inhibitor pantoprazole abrogates adriamycin-resistant gastric cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin signaling and epithelial-mesenchymal transition.
    Zhang B, Yang Y, Shi X, Liao W, Chen M, Cheng AS, Yan H, Fang C, Zhang S, Xu G, Shen S, Huang S, Chen G, Lv Y, Ling T, Zhang X, Wang L, Zhuge Y, Zou X.
    Cancer Lett; 2015 Jan 28; 356(2 Pt B):704-12. PubMed ID: 25449432
    [Abstract] [Full Text] [Related]

  • 5. Pantoprazole pretreatment elevates sensitivity to vincristine in drug-resistant oral epidermoid carcinoma in vitro and in vivo.
    Lu ZN, Shi ZY, Dang YF, Cheng YN, Guan YH, Hao ZJ, Tian B, He HW, Guo XL.
    Biomed Pharmacother; 2019 Dec 28; 120():109478. PubMed ID: 31568987
    [Abstract] [Full Text] [Related]

  • 6. Effect of pantoprazole on human gastric adenocarcinoma SGC7901 cells through regulation of phospho‑LRP6 expression in Wnt/β-catenin signaling.
    Shen W, Zou X, Chen M, Shen Y, Huang S, Guo H, Zhang L, Liu P.
    Oncol Rep; 2013 Aug 28; 30(2):851-5. PubMed ID: 23754096
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The inhibitory effect of pseudolaric acid B on gastric cancer and multidrug resistance via Cox-2/PKC-α/P-gp pathway.
    Sun Q, Li Y.
    PLoS One; 2014 Aug 28; 9(9):e107830. PubMed ID: 25250794
    [Abstract] [Full Text] [Related]

  • 9. Effects of pantoprazole as a HIF-1α inhibitor on human gastric adenocarcinoma sgc-7901 cells.
    Shen Y, Wu Y, Chen M, Shen W, Huang S, Zhang L, Zou X.
    Neoplasma; 2012 Aug 28; 59(2):142-9. PubMed ID: 22248271
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
    Li J, Xu LZ, He KL, Guo WJ, Zheng YH, Xia P, Chen Y.
    Breast Cancer Res; 2001 Aug 28; 3(4):253-63. PubMed ID: 11434876
    [Abstract] [Full Text] [Related]

  • 13. Celastrol Inhibits the Proliferation and Decreases Drug Resistance of Cisplatin- Resistant Gastric Cancer SGC7901/DDP Cells.
    Zhan D, Ni T, Wang H, Lv M, Sunagawa M, Liu Y.
    Anticancer Agents Med Chem; 2022 Aug 28; 22(2):270-279. PubMed ID: 34053427
    [Abstract] [Full Text] [Related]

  • 14. Parthenolide increases the sensitivity of gastric cancer cells to chemotherapy.
    Liu M, Yang Y, Liu D, Cao Y, Li Y.
    J Tradit Chin Med; 2020 Dec 28; 40(6):908-916. PubMed ID: 33258341
    [Abstract] [Full Text] [Related]

  • 15. AP-2α reverses vincristine-induced multidrug resistance of SGC7901 gastric cancer cells by inhibiting the Notch pathway.
    Lian W, Zhang L, Yang L, Chen W.
    Apoptosis; 2017 Jul 28; 22(7):933-941. PubMed ID: 28439677
    [Abstract] [Full Text] [Related]

  • 16. Midkine confers Adriamycin resistance in human gastric cancer cells.
    Xu YY, Mao XY, Song YX, Zhao F, Wang ZN, Zhang WX, Xu HM, Jin F.
    Tumour Biol; 2012 Oct 28; 33(5):1543-8. PubMed ID: 22576950
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Reversal of P-glycoprotein-mediated multi-drug resistance by the E3 ubiquitin ligase Cbl-b in human gastric adenocarcinoma cells.
    Zhang Y, Qu X, Hu X, Yang X, Hou K, Teng Y, Zhang J, Sada K, Liu Y.
    J Pathol; 2009 Jun 28; 218(2):248-55. PubMed ID: 19274672
    [Abstract] [Full Text] [Related]

  • 19. Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer.
    Liu L, Ning X, Sun L, Zhang H, Shi Y, Guo C, Han S, Liu J, Sun S, Han Z, Wu K, Fan D.
    Cancer Sci; 2008 Jan 28; 99(1):121-8. PubMed ID: 17953712
    [Abstract] [Full Text] [Related]

  • 20. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.
    Tang XQ, Bi H, Feng JQ, Cao JG.
    Acta Pharmacol Sin; 2005 Aug 28; 26(8):1009-16. PubMed ID: 16038636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.